VanEck UCITS ETFs plc News - DAVV

Report of Foreign Issuer (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Report of Foreign Issuer (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Report of Foreign Issuer (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Bioblast Announces Effectiveness of Eight to One Reverse Split

Tel Aviv, Israel, March 06, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN), a...

Report of Foreign Issuer (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 F...

Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma

Diversifies Seelos’ pipeline in rare diseases Collaborates with Team Sanfilippo Foundation in development of...

Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics

Unconditional payment of $3.5 million Contingent payment of up to additional $17 million plus royaltiesSeelos...

Report of Foreign Issuer (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Bioblast Pharma Announces Collaboration with Team Sanfilippo to Evaluate Trehalose for the Treatment of Sanfilippo Syndrome...

Tel Aviv, Israel, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN) (“Bioblast”), a...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Report of Foreign Issuer (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 F...

Bioblast Pharma Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Non-Compliance

Tel Aviv, Israel, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN) (“Bioblast” or the...

Report of Foreign Issuer (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Report of Foreign Issuer (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

VanEck UCITS ETFs plc (DAVV)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

DAVV News

Report of Foreign Issuer (6-k)

Report of Foreign Issuer (6-k)

Report of Foreign Issuer (6-k)

Bioblast Announces Effectiveness of Eight to One Reverse Split

Report of Foreign Issuer (6-k)

Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma

Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics

Report of Foreign Issuer (6-k)

Bioblast Pharma Announces Collaboration with Team Sanfilippo to Evaluate Trehalose for the Treatment of Sanfilippo Syndrome...

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Report of Foreign Issuer (6-k)

Bioblast Pharma Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Non-Compliance

Report of Foreign Issuer (6-k)

Report of Foreign Issuer (6-k)

DAVV Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

VanEck UCITS ETFs plc (DAVV) News

VanEck UCITS ETFs plc (DAVV)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

DAVV News

Report of Foreign Issuer (6-k)

Report of Foreign Issuer (6-k)

Report of Foreign Issuer (6-k)

Bioblast Announces Effectiveness of Eight to One Reverse Split

Report of Foreign Issuer (6-k)

Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma

Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics

Report of Foreign Issuer (6-k)

Bioblast Pharma Announces Collaboration with Team Sanfilippo to Evaluate Trehalose for the Treatment of Sanfilippo Syndrome...

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Report of Foreign Issuer (6-k)

Bioblast Pharma Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Non-Compliance

Report of Foreign Issuer (6-k)

Report of Foreign Issuer (6-k)

DAVV Discussion

Your Recent History